🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Leiomyosarcoma

Hypofractionated, 3-week, Preoperative Proton or X-ray Radiotherapy for Patients With Localized Soft Tissue Sarcoma NCT07169344Phase 24 sites📍 Bergen📍 Oslo📍 Tromsø Oslo University Hospital · Tests: preoperative, Quality of life, Functional outcome A Phase 1b, Open-Label Study Of REC-617, A Selective CDK7 Inhibitor, In Patients With Metastatic Or Unresectable RB1-Negative Leiomyosarcoma After Prior Systemic Therapy NCT07633756Phase 11 site📍 Houston M.D. Anderson Cancer Center · Tests: REC617 Letrozole in Uterine Leiomyosarcoma NCT05649956Phase 234 sites📍 Aurora📍 Highlands Ranch📍 Fort Lauderdale GOG Foundation · Tests: Letrozole Interest of Post-operative Chemotherapy in Patients With Localised Uterine Leiomyosarcoma Suspected of Having a High Risk of Recurrence Based on a Biological Test Performed on the Tumour NCT06524583Phase 225 sites📍 Angers📍 Besançon📍 Bordeaux UNICANCER · Tests: Doxorubicin, Trabectedin MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma NCT06277154Phase 21 site📍 Guangzhou HRYZ Biotech Co. · Tests: MASCT-I, Doxorubicin, Ifosfamide Study of All-Trans Retinoic Acid (ATRA) and Cemiplimab in Patients With Advanced Leiomyosarcoma NCT06528769Phase 21 site📍 Columbus Gabriel Tinoco · Tests: all-trans retinoic acid, Cemiplimab, Computed Tomography, Magnetic resonance imaging, Biospecimen Collection Study on the Quality of Life and Pathological State in Patients Who Underwent Radical Cystectomy NCT06170177n/a1 site📍 Milan IRCCS San Raffaele · Tests: Radical Cystectomy IO Combined With AI as First-line Treatment for Patients With Soft Tissue Sarcoma(TAIS) NCT06849986Phase 21 site📍 Shanghai Fudan University · Tests: Tislelizumab+liposomal doxorubicin+ifosfamide Metronomic Trabectedin, Gemcitabine, and Dacarbazine for Soft Tissue Sarcoma NCT04535271Phase 21 site📍 Santa Monica Sarcoma Oncology Research Center, LLC · Tests: Trabectedin NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) NCT06239272Phase 1, Phase 27 sites📍 Atlanta📍 Chicago📍 Baton Rouge St. Jude Children's Research Hospital · Tests: Surgical resection, Proton beam radiation therapy, Pazopanib, Ifosfamide, Doxorubicin Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors NCT07628634EARLY Phase 11 site📍 Orange University of California, Irvine · Tests: Methionine-Reduced Diet Trial in Patients With Metastatic or Locally Advanced Leiomyosarcoma NCT04383119Phase 217 sites📍 Bologna📍 Meldola📍 Prato Italian Sarcoma Group · Tests: Trabectedin, Gemcitabine, No Intervention: Observational Cohort Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone Sarcomas NCT04055220NA16 sites📍 Besançon📍 Bordeaux📍 Lille Centre Leon Berard · Tests: Treatment by Regorafenib, Surveillance Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a2 sites📍 Sioux Falls📍 Sydney Sanford Health Localized Leiomyosarcoma Biomarker Protocol NCT04925089n/a3 sites📍 Ann Arbor📍 Rochester📍 Nashville University of Michigan Rogel Cancer Center · Tests: Blood and Tissue collection Zanzalintinib Combined With Eribulin in Advanced Liposarcoma and Leiomyosarcoma NCT06957431Phase 11 site📍 St Louis Washington University School of Medicine · Tests: Zanzalintinib, Eribulin Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS) NCT03016819Phase 324 sites📍 Phoenix📍 Los Angeles📍 Santa Monica Advenchen Laboratories, LLC · Tests: AL3818, Dacarbazine, AL3818 or placebo, Midazolam 2 mg for CYP3A4 phenotyping, Digoxin (0.25mg) Metastatic Leiomyosarcoma Biomarker Protocol NCT05653388n/a11 sites📍 Santa Monica📍 Miami📍 Boston University of Michigan Rogel Cancer Center · Tests: Plasma Collection AOH1996 for the Treatment of Refractory Solid Tumors NCT05227326Phase 13 sites📍 Scottsdale📍 Duarte📍 Long Beach City of Hope Medical Center · Tests: PCNA Inhibitor AOH1996 Dose-escalated, Hypofractionated, Definitive Proton Radiotherapy for Patients With Inoperable Soft Tissue Sarcoma. NCT07173972Phase 22 sites📍 Bergen📍 Oslo Oslo University Hospital · Tests: Definitive radiotherapy A French Multicenter Observational Retrospective Study of Rare Primary Liver Cancers NCT06541652n/a40 sites📍 Amiens📍 Angers📍 Beauvais Federation Francophone de Cancerologie Digestive Ph 2 Elacestrant in ER Positive Uterine Sarcomas NCT07467772Phase 21 site📍 Boston Dana-Farber Cancer Institute · Tests: Elacestrant Trabectedin Plus Radiotherapy in Soft Tissue Sarcoma Patients NCT02275286Phase 1, Phase 217 sites📍 Bordeaux📍 Lyon📍 Rozzano Grupo Espanol de Investigacion en Sarcomas · Tests: Trabectedin, Radiotherapy Phase II Decentralized Pragmatic Trial of Adjuvant Doxorubicin - Trabectedin Chemotherapy in uLMS NCT07076186Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Trabectedin, Doxorubicin Hydrochloride XL092 (Zanzalintinib) for the Treatment of Patients With Metastatic or Unresectable Leiomyosarcoma, Bone Sarcoma or Translocation-associated Soft Tissue Sarcoma NCT06571734Phase 21 site📍 Chicago Northwestern University · Tests: Biospecimen Collection, Computed Tomography, Echocardiography, Multigated Acquisition Scan, Zanzalintinib A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors NCT06789172Phase 110 sites📍 Beverly Hills📍 Santa Monica📍 Houston Epkin · Tests: OKN4395, Pembrolizumab, Fasting, Fed, H2 Receptor Antagonist STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas NCT06975293Phase 1, Phase 214 sites📍 San Francisco📍 Miami📍 Boston STORM Therapeutics LTD · Tests: STC-15 in combination with toripalimab, STC-15 monotherapy Testing the Addition of an Anti-cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (Gemcitabine) for Soft Tissue Sarcoma NCT06498648Phase 1, Phase 21 site📍 Houston National Cancer Institute (NCI) · Tests: Abemaciclib, Biopsy Procedure, Biospecimen Collection, Computed Tomography, Docetaxel Beliefs, Attitudes, and Response to Genetic Testing in SarcomaPatients NCT06875700n/a1 site📍 Salt Lake City University of Utah Precision Medicine Approaches for Neoadjuvant Therapy in High-risk Sarcoma Patients NCT07432932n/a1 site📍 London Royal Marsden NHS Foundation Trust · Tests: Observational Translational Study
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy